CRISPR THERAPEUTICS AG Increase (Decrease) in Prepaid Expense and Other Assets
CRISPR THERAPEUTICS AG (CRSP) reported Increase (Decrease) in Prepaid Expense and Other Assets of $1.09 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-03.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets · last filed 2026-08-03
- CRISPR THERAPEUTICS AG increase (decrease) in prepaid expense and other assets for the quarter ending 2026-06-30 was $841.00K, a 804.30% increase year-over-year.
- CRISPR THERAPEUTICS AG increase (decrease) in prepaid expense and other assets for the quarter ending 2026-03-31 was $247.00K, a 61.04% decline year-over-year.
- CRISPR THERAPEUTICS AG increase (decrease) in prepaid expense and other assets for the quarter ending 2025-12-31 was -$3.85M.
- CRISPR THERAPEUTICS AG increase (decrease) in prepaid expense and other assets for the quarter ending 2025-09-30 was -$212.00K, a 212.77% decline year-over-year.
- CRISPR THERAPEUTICS AG increase (decrease) in prepaid expense and other assets for fiscal 2025 was -$3.34M.
- CRISPR THERAPEUTICS AG increase (decrease) in prepaid expense and other assets for fiscal 2024 was -$5.29M.
- CRISPR THERAPEUTICS AG increase (decrease) in prepaid expense and other assets for fiscal 2023 was -$23.22M.
- CRISPR THERAPEUTICS AG increase (decrease) in prepaid expense and other assets for fiscal 2022 was -$1.60M, a 111.49% decline from fiscal 2021.
| Period end | Increase (Decrease) in Prepaid Expense and Other Assets 3 month | Increase (Decrease) in Prepaid Expense and Other Assets 6 month | Increase (Decrease) in Prepaid Expense and Other Assets 9 month | Increase (Decrease) in Prepaid Expense and Other Assets 12 month |
|---|---|---|---|---|
| 2026-06-30 | $841.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-03 | $1.09M 10-Q · filed 2026-08-03 | -$2.76M derived: sum of 3 quarters · filed 2026-08-03 | -$2.98M derived: sum of 4 quarters · filed 2026-08-03 |
| 2026-03-31 | $247.00K 10-Q · filed 2026-05-04 | -$3.60M derived: sum of 2 quarters · filed 2026-05-04 | -$3.82M derived: sum of 3 quarters · filed 2026-05-04 | -$3.72M derived: sum of 4 quarters · filed 2026-08-03 |
| 2025-12-31 | -$3.85M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-12 | -$4.06M derived: sum of 2 quarters · filed 2026-02-12 | -$3.97M derived: sum of 3 quarters · filed 2026-08-03 | -$3.34M 10-K · filed 2026-02-12 |
| 2025-09-30 | -$212.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | -$119.00K derived: sum of 2 quarters · filed 2026-08-03 | $515.00K 10-Q · filed 2025-11-10 | $339.00K derived: sum of 4 quarters · filed 2026-08-03 |
| 2025-06-30 | $93.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-03 | $727.00K 10-Q · filed 2026-08-03 | $551.00K derived: sum of 3 quarters · filed 2026-08-03 | $739.00K derived: sum of 4 quarters · filed 2026-08-03 |
| 2025-03-31 | $634.00K 10-Q · filed 2026-05-04 | $458.00K derived: sum of 2 quarters · filed 2026-05-04 | $646.00K derived: sum of 3 quarters · filed 2026-05-04 | -$1.70M derived: sum of 4 quarters · filed 2026-05-04 |
| 2024-12-31 | -$176.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-12 | $12.00K derived: sum of 2 quarters · filed 2026-02-12 | -$2.34M derived: sum of 3 quarters · filed 2026-02-12 | -$5.29M 10-K · filed 2026-02-12 |
| 2024-09-30 | $188.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | -$2.16M derived: sum of 2 quarters · filed 2025-11-10 | -$5.11M 10-Q · filed 2025-11-10 | -$11.56M derived: sum of 4 quarters · filed 2026-02-12 |
| 2024-06-30 | -$2.35M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-04 | -$5.30M 10-Q · filed 2025-08-04 | -$11.75M derived: sum of 3 quarters · filed 2026-02-12 | -$12.56M derived: sum of 4 quarters · filed 2026-02-12 |
| 2024-03-31 | -$2.95M 10-Q · filed 2025-05-06 | -$9.40M derived: sum of 2 quarters · filed 2026-02-12 | -$10.22M derived: sum of 3 quarters · filed 2026-02-12 | -$14.13M derived: sum of 4 quarters · filed 2026-02-12 |
| 2023-12-31 | -$6.45M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-12 | -$7.27M derived: sum of 2 quarters · filed 2026-02-12 | -$11.18M derived: sum of 3 quarters · filed 2026-02-12 | -$23.22M 10-K · filed 2026-02-12 |
| 2023-09-30 | -$817.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-05 | -$4.73M derived: sum of 2 quarters · filed 2024-11-05 | -$16.77M 10-Q · filed 2024-11-05 | -$11.30M derived: sum of 4 quarters · filed 2025-02-11 |
| 2023-06-30 | -$3.91M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-05 | -$15.95M 10-Q · filed 2024-08-05 | -$10.49M derived: sum of 3 quarters · filed 2025-02-11 | -$15.52M derived: sum of 4 quarters · filed 2025-02-11 |
| 2023-03-31 | -$12.04M 10-Q · filed 2024-05-08 | -$6.58M derived: sum of 2 quarters · filed 2025-02-11 | -$11.61M derived: sum of 3 quarters · filed 2025-02-11 | -$9.03M derived: sum of 4 quarters · filed 2025-02-11 |
| 2022-12-31 | $5.46M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-11 | $434.00K derived: sum of 2 quarters · filed 2025-02-11 | $3.01M derived: sum of 3 quarters · filed 2025-02-11 | -$1.60M 10-K · filed 2025-02-11 |
| 2022-09-30 | -$5.03M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-06 | -$2.45M derived: sum of 2 quarters · filed 2023-11-06 | -$7.06M 10-Q · filed 2023-11-06 | -$11.93M derived: sum of 4 quarters · filed 2024-02-21 |
| 2022-06-30 | $2.58M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-07 | -$2.03M 10-Q · filed 2023-08-07 | -$6.89M derived: sum of 3 quarters · filed 2024-02-21 | $2.41M derived: sum of 4 quarters · filed 2024-02-21 |
| 2022-03-31 | -$4.61M 10-Q · filed 2022-05-09 | -$9.47M derived: sum of 2 quarters · filed 2024-02-21 | -$169.00K derived: sum of 3 quarters · filed 2024-02-21 | $4.23M derived: sum of 4 quarters · filed 2024-02-21 |
| 2021-12-31 | -$4.86M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-21 | $4.44M derived: sum of 2 quarters · filed 2024-02-21 | $8.84M derived: sum of 3 quarters · filed 2024-02-21 | $13.91M 10-K · filed 2024-02-21 |
| 2021-09-30 | $9.30M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-01 | $13.71M derived: sum of 2 quarters · filed 2022-11-01 | $18.77M 10-Q · filed 2022-11-01 | $20.71M derived: sum of 4 quarters · filed 2023-02-21 |
| 2021-06-30 | $4.40M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | $9.47M 10-Q · filed 2022-08-08 | $11.40M derived: sum of 3 quarters · filed 2023-02-21 | $15.73M derived: sum of 4 quarters · filed 2023-02-21 |
| 2021-03-31 | $5.07M 10-Q · filed 2022-05-09 | $7.00M derived: sum of 2 quarters · filed 2023-02-21 | $11.32M derived: sum of 3 quarters · filed 2023-02-21 | $17.39M derived: sum of 4 quarters · filed 2023-02-21 |
| 2020-12-31 | $1.94M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-21 | $6.26M derived: sum of 2 quarters · filed 2023-02-21 | $12.32M derived: sum of 3 quarters · filed 2023-02-21 | -$17.34M 10-K · filed 2023-02-21 |
| 2020-09-30 | $4.32M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-03 | $10.39M derived: sum of 2 quarters · filed 2021-11-03 | -$19.27M 10-Q · filed 2021-11-03 | -$12.00M derived: sum of 4 quarters · filed 2022-02-15 |
| 2020-06-30 | $6.06M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-29 | -$23.59M 10-Q · filed 2021-07-29 | -$16.32M derived: sum of 3 quarters · filed 2022-02-15 | $7.62M derived: sum of 4 quarters · filed 2022-02-15 |
| 2020-03-31 | -$29.66M 10-Q · filed 2021-04-27 | -$22.38M derived: sum of 2 quarters · filed 2022-02-15 | $1.56M derived: sum of 3 quarters · filed 2022-02-15 | -$92.00K derived: sum of 4 quarters · filed 2022-02-15 |
| 2019-12-31 | $7.28M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-15 | $31.22M derived: sum of 2 quarters · filed 2022-02-15 | $29.57M derived: sum of 3 quarters · filed 2022-02-15 | $32.62M 10-K · filed 2022-02-15 |
| 2019-09-30 | $23.94M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-28 | $22.29M derived: sum of 2 quarters · filed 2020-10-28 | $25.34M 10-Q · filed 2020-10-28 | $26.18M derived: sum of 4 quarters · filed 2021-02-16 |
| 2019-06-30 | -$1.65M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-27 | $1.40M 10-Q · filed 2020-07-27 | $2.24M derived: sum of 3 quarters · filed 2021-02-16 | $937.00K derived: sum of 4 quarters · filed 2021-02-16 |
| 2019-03-31 | $3.05M 10-Q · filed 2020-04-28 | $3.89M derived: sum of 2 quarters · filed 2021-02-16 | $2.59M derived: sum of 3 quarters · filed 2021-02-16 | $3.97M derived: sum of 4 quarters · filed 2021-02-16 |
| 2018-12-31 | $840.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-16 | -$462.00K derived: sum of 2 quarters · filed 2021-02-16 | $916.00K derived: sum of 3 quarters · filed 2021-02-16 | $3.34M 10-K · filed 2021-02-16 |
| 2018-09-30 | -$1.30M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-28 | $76.00K derived: sum of 2 quarters · filed 2019-10-28 | $2.50M 10-Q · filed 2019-10-28 | $6.32M derived: sum of 4 quarters · filed 2020-02-12 |
| 2018-06-30 | $1.38M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-29 | $3.80M 10-Q · filed 2019-07-29 | $7.62M derived: sum of 3 quarters · filed 2020-02-12 | $7.18M derived: sum of 4 quarters · filed 2020-02-12 |
| 2018-03-31 | $2.43M 10-Q · filed 2019-04-29 | $6.24M derived: sum of 2 quarters · filed 2020-02-12 | $5.81M derived: sum of 3 quarters · filed 2020-02-12 | $6.15M derived: sum of 4 quarters · filed 2020-02-12 |
| 2017-12-31 | $3.81M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-12 | $3.38M derived: sum of 2 quarters · filed 2020-02-12 | $3.72M derived: sum of 3 quarters · filed 2020-02-12 | $4.12M 10-K · filed 2020-02-12 |
| 2017-09-30 | -$432.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-07 | -$90.00K derived: sum of 2 quarters · filed 2018-11-07 | $304.00K 10-Q · filed 2018-11-07 | $681.00K derived: sum of 4 quarters · filed 2019-02-25 |
| 2017-06-30 | $342.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-07 | $736.00K 10-Q · filed 2018-08-07 | $1.11M derived: sum of 3 quarters · filed 2019-02-25 | -$766.00K derived: sum of 4 quarters · filed 2019-02-25 |
| 2017-03-31 | $394.00K 10-Q · filed 2018-05-08 | $771.00K derived: sum of 2 quarters · filed 2019-02-25 | -$1.11M derived: sum of 3 quarters · filed 2019-02-25 | $472.00K derived: sum of 4 quarters · filed 2019-02-25 |
| 2016-12-31 | $377.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-25 | -$1.50M derived: sum of 2 quarters · filed 2019-02-25 | $78.00K derived: sum of 3 quarters · filed 2019-02-25 | $1.07M 10-K · filed 2019-02-25 |
| 2016-09-30 | -$1.88M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-08 | -$299.00K derived: sum of 2 quarters · filed 2017-11-08 | $694.00K 10-Q · filed 2017-11-08 | $801.00K derived: sum of 4 quarters · filed 2018-03-08 |
| 2016-06-30 | $1.58M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-10 | $2.57M 10-Q · filed 2017-08-10 | $2.68M derived: sum of 3 quarters · filed 2018-03-08 | |
| 2016-03-31 | $993.00K 10-Q · filed 2017-05-11 | $1.10M derived: sum of 2 quarters · filed 2018-03-08 | ||
| 2015-12-31 | $107.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-08 | $620.00K 10-K · filed 2018-03-08 | ||
| 2015-09-30 | $513.00K 10-Q · filed 2016-11-22 | |||
| 2014-12-31 | $12.00K 10-K · filed 2017-03-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IOVANCE BIOTHERAPEUTICS, INC. (IOVA) | United States | $4.897B | -6.51 |
| Scholar Rock Holding Corp (SRRK) | United States | $5.920B | -16.37 |
| Adaptive Biotechnologies Corp (ADPT) | United States | $4.719B | -53.43 |
| CG Oncology, Inc. (CGON) | United States | $6.095B | -27.95 |
| Relay Therapeutics, Inc. (RLAY) | United States | $3.884B | -14.30 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |
| Tarsus Pharmaceuticals, Inc. (TARS) | United States | $3.329B | -58.60 |
| Denali Therapeutics Inc. (DNLI) | United States | $3.274B | -8.04 |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| Greenland Mines Ltd (GRML) | United States | $2.362B |